Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery
Sponsor: Brigham and Women's Hospital
Terminated
slow enrollment, outcome measures collected but actual enrollment is below target enrollment
Other terminated trials from Brigham and Women's Hospital
Other Postpartum Hemorrhage trials with similar outcome
This NA trial investigates Postpartum Hemorrhage and is currently terminated or withdrawn. Brigham and Women's Hospital leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Terminated NA
-
Sep 2024 — Feb 2026 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
▶ Show 9 earlier versions
-
Sep 2021 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Sep 2021 [monthly]
Terminated NA
-
Jul 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Mar 2020 — Jul 2020 [monthly]
Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Recruiting NA
-
Jan 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2017 — Nov 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .